跳至主要内容
临床试验/NCT05706805
NCT05706805已完成不适用

NAVISCORE Post-Market Clinical Follow-up Study

Fundación EPIC7 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2023年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
7
主要终点
Safety Endpoint. Freedom from Target Lesion Failure

研究概览

简要总结

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Naviscore scoring balloon to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Naviscore.

详细描述

The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the Naviscore scoring balloon in a NON-SELECTED, Real World population under daily clinical practice when used as intended by the manufacturer to meet EU Medical Device regulation requirements for post-market clinical follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient treated with Naviscore according to routine hospital practice and following instructions for use
  • Informed consent signed

排除标准

  • Not meet inclusion criteria

结局指标

主要结局

Safety Endpoint. Freedom from Target Lesion Failure

时间窗: 7 days

Freedom from TARGET LESION FAILURE (TLF), composite endpoint of cardiac death, myocardial infarction (MI) and a new Target Lesion Revascularization (TLR).

次要结局

  • Efficacy Endpoint. Freedom from Target Lesion Failure (TLF)(7 days)
  • Freedom from Coronary perforation(During PCI (Percutaneous Coronary Intervention))
  • Freedom from Hypotube rupture(During PCI (Percutaneous Coronary Intervention))
  • Freedom from Complicated withdrawal(During PCI (Percutaneous Coronary Intervention))
  • Freedom from Balloon rupture(During PCI (Percutaneous Coronary Intervention))
  • Freedom from Coronary dissection >C(During PCI (Percutaneous Coronary Intervention))
  • Freedom from Coronary thrombosis(During PCI (Percutaneous Coronary Intervention))
  • Freedom from No reflow(During PCI (Percutaneous Coronary Intervention))

研究者

发起方
Fundación EPIC
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

NAVISCORE PMCF Study ( rEPIC04F ) | 临床试验